Long-Term Efficacy of a Percutaneously Adjustable Hydraulic Urethral Sphincter for Treatment of Urinary Incontinence in Four Dogs

Objective— To evaluate the efficacy of a surgically placed, static hydraulic urethral sphincter (SHUS) for treatment of urethral sphincter mechanism incompetency (USMI).
Study Design— Prospective study.
Animals— Spayed female dogs (n=4) with acquired USMI.
Methods— Urinary incontinence was assessed using a subjective continence score before and after implantation of an SHUS on the proximal urethra via ventral median celiotomy. Dogs were assessed for urinary continence, urinary tract infections, and implant-associated complications for 30 months. Residual incontinence was treated with percutaneous inflation of the SHUS with sterile saline solution through a biocompatible subcutaneous administration port.
Results— At last follow-up (26–30 months after surgery), continence scores improved from a median preoperative score of 3/10 to a median postoperative score of 10. One dog developed wound drainage over the subcutaneously placed administration port but remained continent after port removal. Three occluders were percutaneously filled with additional saline (median, 0.18 mL; mean, 0.16 mL) to improve continence after surgery.
Conclusions— Application and adjustment of an SHUS provided sustained improvements in continence score in all dogs.
Clinical Relevance— In this pilot study, 3 of 4 dogs with hydraulic urethral sphincter implantation had successful percutaneous adjustment and maintained improved continence scores for 2 years after surgery. Continence was maintained in the 4th dog even after administration port removal. Based on this pilot study, the SHUS warrants further clinical evaluation for treatment of dogs with USMI unresponsive to medical management.     

Survey of Feeding Practices, Supplement Use, and Knowledge of Equine Nutrition among a Subpopulation of Horse Owners in New England

Nutrition is a critical component of equine health. Horse owners' knowledge of nutrition is likely to affect their feeding practices. The aim of this study was to survey feeding practices, dietary supplement use, and knowledge about equine nutrition in New England by surveying a subpopulation of horse owners (67/337 or 19.8%) who brought their horses to the Large Animal Hospital at the Cummings School of Veterinary Medicine at Tufts University between July and September 2008. All owners reported feeding hay, with the majority feeding grass or timothy hay. Most owners (96%) reported feeding a concentrate in addition to hay. Approximately 84% of owners reported including at least one dietary supplement in their horse's daily feeding. The most commonly used supplements were chondroprotectives, electrolytes, and multivitamins. Survey questions designed to assess the owner's knowledge of nutrition suggested that many owners may not have a basic understanding of principles of equine nutrition; less than 50% knew the daily water and hay requirements for a horse, and 69% lacked knowledge about the proper use of concentrates in a diet. Most of the surveyed owners consulted multiple sources of information concerning equine nutrition, including veterinarians (n = 36), trainers (n = 27), feed stores (n = 10), and the internet (n = 7). Although the major source of information was the veterinarian, it appears that the communication between horse owners and their veterinarian about optimal feeding practices could be enhanced. This survey demonstrated areas in the veterinarian–client dialog that need to be addressed when evaluating the health and well-being of the horse.     

Cloning and sequencing of FSH-β and LH-β subunits and changes in their expression during the reproductive cycle in the three-spined stickleback, Gasterosteus aculeatus

To achieve a better understanding of the role of gonadotropins (GTHs) in the stickleback we have cloned the full-length cDNAs of the β-subunits of follicle stimulating hormone (FSH) and luteinizing hormone (LH), and analysed the expression during the seasonal cycle. In females, LH-β levels were low during winter and early spring, increased to a peak in late May and declined to low levels again in July. FSH-β expression peaked earlier, in January and declined spring. In males, LH-β expression peaked in May. During June–September, when spermatogenesis occurs, LH-β levels were very low. FSH-β expression peaked earlier, in January, and reached the lowest levels in July. Thus, when spermatogenesis starts, the expression of both GTH-β mRNAs display their lowest levels.